The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome

Antimicrobial Agents and Chemotherapy
Tatiana BaranovichElena A Govorkova

Abstract

Most cases of severe influenza are associated with pulmonary complications, such as acute respiratory distress syndrome (ARDS), and no antiviral drugs of proven value for treating such complications are currently available. The use of monoclonal antibodies targeting the stem of the influenza virus surface hemagglutinin (HA) is a rapidly developing strategy for the control of viruses of multiple HA subtypes. However, the mechanisms of action of these antibodies are not fully understood, and their ability to mitigate severe complications of influenza has been poorly studied. We evaluated the effect of treatment with VIS410, a human monoclonal antibody targeting the HA stem region, on the development of ARDS in BALB/c mice after infection with influenza A(H7N9) viruses. Prophylactic administration of VIS410 resulted in the complete protection of mice against lethal A(H7N9) virus challenge. A single therapeutic dose of VIS410 given 24 h after virus inoculation resulted in dose-dependent protection of up to 100% of mice inoculated with neuraminidase inhibitor-susceptible or -resistant A(H7N9) viruses. Compared to the outcomes in mock-treated controls, a single administration of VIS410 improved viral clearance from the lungs, reduced...Continue Reading

References

Mar 17, 1999·British Journal of Pharmacology·P BalukD M McDonald
Dec 24, 2005·The New England Journal of Medicine·Menno D de JongJeremy Farrar
Dec 28, 2005·Journal of Virology·Zhongyu ZhuDimiter S Dimitrov
Aug 31, 2006·Annals of Internal Medicine·Thomas C LukeStephen L Hoffman
Dec 11, 2007·Nature Biotechnology·Wayne A Marasco, Jianhua Sui
Feb 21, 2009·Vaccine·Thijs Kuiken, Jeffery K Taubenberger
Jun 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy M Uyeki
Jan 21, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ivan Fn HungKwok-Yung Yuen
May 3, 2011·American Journal of Respiratory Cell and Molecular Biology·Gustavo Matute-BelloUNKNOWN Acute Lung Injury in Animals Study Group
May 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Gui-Mei LiRafi Ahmed
Aug 11, 2012·Science·Cyrille DreyfusRobert H E Friesen
Aug 29, 2012·The Journal of Infectious Diseases·Paul K S ChanNancy A Dreyer
Oct 4, 2012·JAMA : the Journal of the American Medical Association·Stephen FröhlichJohn Boylan
Apr 13, 2013·The New England Journal of Medicine·Rongbao GaoYuelong Shu
Jul 11, 2013·Clinical & Developmental Immunology·Marcello LanariGiacomo Faldella
Aug 24, 2013·Emerging Infectious Diseases·Katrina SleemanLarisa V Gubareva
Aug 28, 2013·Current Opinion in Virology·Florian Krammer, Peter Palese
Sep 13, 2013·Journal of Virology·Kathryn A Hooper, Jesse D Bloom
Nov 19, 2013·The Lancet Infectious Diseases·Kirsty R ShortThijs Kuiken
Dec 19, 2013·PloS One·Boerries BrandenburgRobert H E Friesen
Sep 12, 2014·Journal of Virology·Victoria A MeliopoulosStacey Schultz-Cherry
Feb 18, 2015·The Journal of Clinical Investigation·Carole J Henry DunandPatrick C Wilson
Apr 9, 2015·Nature Communications·Hassan ZaraketRichard J Webby
Apr 29, 2015·Current Opinion in Virology·Karthik ViswanathanGregory J Babcock
Jul 29, 2015·Frontiers in Immunology·Zachary ShriverRam Sasisekharan
Aug 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Kannan TharakaramanZachary Shriver

❮ Previous
Next ❯

Citations

Oct 19, 2016·Trends in Microbiology·Boopathy RamakrishnanRam Sasisekharan
Nov 1, 2016·Expert Review of Clinical Pharmacology·Aisling Mc Mahon, Ignacio Martin-Loeches
Feb 2, 2017·Influenza and Other Respiratory Viruses·Paulina KoszalkaAeron C Hurt
Jul 24, 2018·Expert Opinion on Emerging Drugs·Marco ManteroMarta Di Pasquale
Aug 11, 2019·Current Pharmaceutical Biotechnology·Miriam DiboLígia C Faccin-Galhardi
Jul 13, 2018·BioMed Research International·Urai Chaisri, Wanpen Chaicumpa
Jun 14, 2019·Frontiers in Medicine·Nicola PrincipiSusanna Esposito
Sep 27, 2018·Frontiers in Immunology·Sophia Davidson
Aug 2, 2019·Current Drug Targets·Doreen Szollosi, Ashley Bill
Mar 3, 2020·Frontiers in Microbiology·Olivia A Vogel, Balaji Manicassamy
Dec 22, 2017·NPJ Vaccines·Georgina SalazarZhiqiang An
Dec 5, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Samuel K LaiRaymond J Pickles
Jul 20, 2019·Antiviral Research·Koen Sedeyn, Xavier Saelens
Dec 15, 2020·Advanced Drug Delivery Reviews·Carlos Cruz-TeranSamuel K Lai
Oct 26, 2020·Drug Discovery Today·Rick HeidaHenderik W Frijlink
Feb 12, 2020·Cold Spring Harbor Perspectives in Medicine·John H Beigel, Frederick G Hayden
Aug 7, 2021·Critical Reviews in Microbiology·Fanhua WeiYujiong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.